SQZ BIOTECH
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
SQZ BIOTECH
Industry:
Biotechnology Life Science Therapeutics
Founded:
2013-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.sqzbiotech.com
Total Employee:
101+
Status:
Active
Contact:
617-758-8672
Email Addresses:
[email protected]
Total Funding:
229.81 M USD
Technology used in webpage:
Content Delivery Network Amazon HSTS IPv6 Cloudflare Hosting Facebook Sharer Cloudflare CDN ReCAPTCHA V2 Amazon Virginia Region COVID-19
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute of General Medical Science
National Institute of General Medical Science investment in Grant - SQZ Biotech
Invus
Invus investment in Series D - SQZ Biotech
Polaris Partners
Polaris Partners investment in Series D - SQZ Biotech
Illumina Ventures
Illumina Ventures investment in Series D - SQZ Biotech
JDRF T1D Fund
JDRF T1D Fund investment in Series D - SQZ Biotech
Google Ventures
Google Ventures investment in Series D - SQZ Biotech
+ND Capital
+ND Capital investment in Series D - SQZ Biotech
Nano Dimension
Nano Dimension investment in Series D - SQZ Biotech
Temasek Holdings
Temasek Holdings investment in Series D - SQZ Biotech
Google Ventures
Google Ventures investment in Series D - SQZ Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-11 | SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer |
More informations about "SQZ Biotech"
SQZ Biotech - Crunchbase Company Profile & Funding
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary …See details»
SQZ Biotech Company Profile 2024: Valuation, Investors
SQZ Biotech General Information Description. SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, …See details»
SQZBiotech - Company Profile - Tracxn
Nov 27, 2024 SQZBiotech. has raised a total funding of $168M over 12 rounds. What are the most recent funding rounds of SQZBiotech? Its latest funding round was a Grant (prize …See details»
SQZ Company Profile | Management and Employees List - Datanyze
[email protected]: SQZ Top Competitors. Company Employees Revenue Top technologies; ViaCyte Inc. 107: $22.6 M: TCR2 Therapeutics. 137: $29 M: MaxCyte Inc. 125: $42 M: …See details»
SQZ Biotech - Craft
Sep 1, 2023 SQZ Biotechnologies is a company that develops cell therapies for patients with cancer and infectious diseases. It uses Cell Squeeze, a method to physically squeeze cells …See details»
Empower Cells to Change Lives - sqzbiotech.com
Www.sqzbiotech.com. About World Economic Forum. The World Economic Forum, committed to improving the state of the world, is the International Organization for Public -Private …See details»
SQZ founder Armon Sharei opens new Portal to cell …
Dec 12, 2023 As SQZ Biotechnologies slips away, the biotech’s founder and former CEO Armon Sharei, Ph.D., is launching a new cell engineering platform outfit dubbed Portal Biotechnologies.See details»
SQZ Biotech is on Inc.'s 30 Under 30 List - Inc.com
May 24, 2016 SQZ Biotech: This young engineer landed $500 million to develop a new way to fight cancerSee details»
Sqz Biotechnologies Company (SQZ-N) Profile - The ... - The Globe …
See the company profile for Sqz Biotechnologies Company (SQZ-N) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
SQZ Biotech Receives Investment from JDRF T1D Fund
Dec 5, 2017 For more information please visit www.sqzbiotech.com. JDRF T1D Fund Contact: Amy Montalto National Director [email protected] 617-910-7542. SQZ Contact: Rebecca Cohen Manager, Corporate Relations & …See details»
SQZ Biotech | STEX - Startup
Apr 6, 2020 CellSqueeze is being evaluated as a delivery platform by several dozen academic institutions and biotech firms. The technology lends itself to a wide variety of drug discovery and target validation applications, and one day, …See details»
SQZ Biotechnologies Company (SQZB) - Stock Analysis
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.See details»
SQZ Biotechnologies Company (SQZB) - Yahoo Finance Canada
Find the latest SQZ Biotechnologies Company (SQZB) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
SQZ Biotechnologies seeks to expand the universe of cell …
Immune cell-based therapies have become a critical weapon against cancer and can drive durable patient benefit yet the arsenal of therapies is limited by current cell engineering …See details»
SQZ Biotechnologies Announces FDA Clearance of IND …
Feb 1, 2021 SQZ Biotechnologies IR Contact: Rebecca Cohen Corporate and Investor Relations [email protected] 617-758-8672 ext. 728 Media Contact: Kate Contreras …See details»
SQZ Biotechnologies Announces FDA Clearance of ... - Business Wire
Jan 24, 2022 Media Contact John Lacey Corporate Communications [email protected] 781-392-5514 Contacts. Investor Relations Contact …See details»
SQZ Biotechnologies Provides Update on Collaboration with Roche
Jul 25, 2023 SQZ Biotechnologies Investor and Media Relations: Mike Kaiser [email protected] 857-760-0398 Site Navigation. Home. Home; Submit a Press …See details»
SQZ Biotechnologies Strengthens Board with Global Commercial …
Jul 1, 2021 SQZ Biotechnologies IR: [email protected]. SQZ Biotechnologies Media: John Lacey Corporate Communications [email protected] 781-392-5514 Site …See details»
SQZBiotechnologiesseekstoexpand theuniverseofcelltherapies
ADVETSEMET EATURE ADVERTISER RETAINS SOLE RESPONSIBILITY FOR CONTENT SQZBiotechnologies www.sqzbiotech.com SQZBiotechnologiesseekstoexpand …See details»
SQZ Biotechnologies Presents Regenerative Medicine Data …
Jun 23, 2021 SQZ Biotechnologies IR Contact: [email protected] SQZ Biotechnologies Media Contact: John Lacey Corporate Communications [email protected] 781-392 …See details»